Related Experiment Video
Updated: Jun 12, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
[Antifungal therapy in special situations: resistant candidiasis and aspergillosis]
1Departamento de Medicina Interna, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Abstract:
Fungal infections are an increasingly frequent problem in oncohematological patients with febrile neutropenia and hematopoietic precursors transplant recipients. According to the definitions of the EORTC/MSG Consensus Group, the term invasive fungal infection (IFI) is preferred nowadays to name this group of infections. This aims at highlighting the complex disease resulting from a fungal infection involving higher morbidity, longer hospital stays, increased health care costs and higher mortality risk. Candidiasis and aspergillosis account for about 80% of IFIs in oncohematological patients, while Fusarium diseases, mucormycosis, among others, are emerging infections.
Insights
Invasive fungal infections (IFIs) are a growing concern for cancer patients and transplant recipients. These complex infections lead to worse outcomes, longer hospitalizations, and increased mortality.
Area of Science:
- Oncology
- Mycology
- Infectious Diseases
Context:
- Oncohematological patients with febrile neutropenia are at high risk.
- Hematopoietic precursor transplant recipients face increased susceptibility.
- Invasive fungal infections (IFIs) present significant clinical challenges.
Purpose:
- To define and highlight the severity of invasive fungal infections (IFIs).
- To emphasize the impact of IFIs on patient outcomes and healthcare resources.
- To identify common and emerging fungal pathogens in immunocompromised populations.
Summary:
- Invasive fungal infections (IFIs) are increasingly prevalent in immunocompromised patients, particularly in oncohematology and transplant settings.
- Candidiasis and aspergillosis represent the majority of IFIs, while Fusarium and mucormycosis are emerging threats.
- The term invasive fungal infection (IFI) underscores the associated morbidity, prolonged hospital stays, elevated costs, and mortality risk.
Impact:
- Improved understanding of IFI burden in vulnerable patient groups.
- Highlights the need for vigilant diagnosis and management strategies.
- Informs clinical practice and resource allocation for IFI prevention and treatment.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Candidiasis
Fungal Phylum Ascomycota
Fungal Phylum Microsporidia
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
